ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk cuts weight-loss drug Wegovy's price by up to 33% in India, document shows
Novo and Lilly are locked in a race for dominance in India, a key battleground for weight-loss treatments in the booming global market, which analysts estimate could be worth 0 billion annually by the end of the decade. "This appears like prices have be
Announcement as on 11 November 2025

Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drug
According to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “But it has to be cautioned that weight loss drugs are not cosmetic medicines. It has to be prescribed to the right pat
Announcement as on 11 November 2025

Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India
Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with Wegovy and follows Eli Lilly's competition in this space. Af
Announcement as on 10 November 2025

Novo Nordisk ties up with Emcure to expand reach of weight-loss drug semaglutide in India
Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide under the brand name Poviztra in India. This collaboration aims to expand access to the drug by leveraging Emcure's extensive distribu
Announcement as on 10 November 2025

Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.

Announcement as on 04 November 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 46.27
  • 12Day Average: 46.57
  • 20Day Average: 46.49
  • 50Day Average: 47.9
  • 100Day Average: 45.9
  • 150Day Average: 44.11
  • 200Day Average: 46.4

NVO Indicators & signals

Indicator MACD (12,26,9)

46.53, 46.78, -0.35
Indicator MACD is in negative zone

Indicator ADX (14)

4.23, 24.83, 22.82
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Fri Sep 2026 46.63 46.04 to 47.45 -1.85% 0.44 times
03 Thu Sep 2026 47.51 46.57 to 48.00 1.6% 0.86 times
02 Wed Sep 2026 46.76 45.17 to 47.01 3.63% 0.9 times
01 Tue Sep 2026 45.12 45.07 to 46.16 -0.46% 0.92 times
31 Mon Aug 2026 45.33 44.95 to 45.61 -0.61% 0.75 times
28 Fri Aug 2026 45.61 45.41 to 46.21 -1.41% 0.84 times
27 Thu Aug 2026 46.26 45.70 to 46.33 -1.97% 1.28 times
26 Wed Aug 2026 47.19 46.87 to 48.04 -3.02% 0.88 times
25 Tue Aug 2026 48.66 47.56 to 48.66 3.71% 1.53 times
24 Mon Aug 2026 46.92 46.57 to 47.30 0.39% 0.95 times
21 Fri Aug 2026 46.74 46.34 to 47.17 1.3% 1.08 times
20 Thu Aug 2026 46.14 46.11 to 46.90 -0.71% 0.95 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top